Quest Diagnostics Incorporated
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 11/18/2022   Download
SEC Document
SEC Filing
On November 14, 2022, the Board of Directors (the “Board”) of the Company amended and restated the Company's By-Laws (the "By-Laws"). The amendments (a) revise Sections 1.05, 1.06 and 1.07 with respect to nominations of directors and solicitations of proxies, including compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and (b) incorporate ministerial, clarifying and conforming changes.